definiens: within the meaning of the Private Securities Litigation Reform Act of 1995, as amended . Such statements reflect current beliefs of Enumeral Biomedical Holdings, Inc. ( ) with respect to future events and involve known and unknown risks, uncertainties, and other factors affecting operations, market growth, Enumeral 's stock price, services, products and licenses . No assurances can be given regarding the achievement of future results, and although Enumeral believes that the expectations reflected in these forward - looking statements are based on reasonable assumptions, actual results may differ from the assumptions underlying the statements that have been made regarding anticipated events . Factors that may cause actual results, periormance or achievements, or industry results to differ materially from those contemplated by such forward - looking statements include, among others, the risks that ( a ) Enumeral 's expectations regarding market acceptance of the Company 's business in general and the Company 's ability to penetrate the antibody discovery and development fields in particular, as Schedule 2 - 2 FOIA CONFIDE"ITlAL TREAnlENT REQUESTED BY ENCMERAL BIOMEDICAL HOLDINGS, INC